PNO1 and osteosarcoma: Meanwhile, the levels of TGFB2, p-Smad2, p-Smad3, and BMP-6 showed a reverse trend after the SRI-011381 application, suggesting that PNO1 could influence the progression of osteosarcoma cells via the TGF-β signaling pathway.